Carb10® (Pea Starch Carbohydrate)

Pisum sativum
Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

Carb10® (Compound Solutions) is a patented, non-GMO pea starch (Pisum sativum) carbohydrate ingredient uniquely characterized by a very low glycemic and insulinemic response compared to standard carbohydrates — providing sustained energy delivery without the insulin spike and crash associated with high-GI carbs like dextrose, maltodextrin, or waxy maize. Clinical data shows Carb10® produces 82% less insulin and 27% lower blood glucose response vs. maltodextrin, making it ideal for pre/intra-workout fueling, sustained energy, and applications targeting insulin-sensitive consumers.

Studied Dose 15–25g per serving for workout fueling; can be used pre, intra, or post-workout; suitable for sustained energy formulas at 10–20g
Active Compound Pea starch from Pisum sativum — Carb10® by Compound Solutions; patented non-GMO pea starch with low glycemic and low insulinemic profile; typical molecular weight 100–300 kDa

82% less insulin response than maltodextrin

Clinical testing confirmed Carb10® produces 82% less insulin response and 27% lower blood glucose peak vs. maltodextrin at equivalent carbohydrate doses. This dramatically blunted insulinemic response makes Carb10® uniquely suitable for consumers managing blood sugar, insulin resistance, or seeking sustained energy without the post-carb energy crash driven by reactive hypoglycemia.

Sustained workout energy without GI distress

Carb10's pea starch molecular structure provides a moderate digestion rate that sustains glucose delivery over 2–3 hours — longer than high-GI carbs but without the bloating and GI discomfort associated with fiber-heavy or slowly-digested carbs. Well-tolerated as a pre/intra-workout fuel for sustained performance.

Insulin-sensitive and low-carb compatible fueling

For individuals managing metabolic conditions, following low-glycemic diets, or using time-restricted eating protocols, Carb10® provides carbohydrate energy without the insulin and glucose disruption that can impair metabolic health goals. It bridges the gap between fast-acting high-GI carbs and very slow-digesting resistant starches.

1

Pea starch digestion kinetics and low GI response

Carb10®'s pea starch structure (high amylose content relative to other starches) slows amylase-mediated digestion, releasing glucose more gradually into the bloodstream. The moderate digestion rate avoids the rapid portal glucose flux that triggers robust insulin secretion from pancreatic beta cells — resulting in the 82% lower insulin response documented in Compound Solutions' clinical testing.

1
Carb10® Glycemic and Insulinemic Response vs. Maltodextrin — Clinical Study
PubMed

Comparative clinical study examining blood glucose and insulin response to Carb10® vs. maltodextrin in healthy subjects.

Healthy adults. Acute glycemic response comparison design.

Carb10® produced 82% lower insulin response and 27% lower peak blood glucose vs. equivalent maltodextrin dose. Sustained glucose availability without reactive hypoglycemia. GI tolerance well-rated. Supports Carb10® as a superior carbohydrate for blood sugar management applications.

Common Potential side effects

Generally very well tolerated; pea-derived, non-GMO
Mild bloating during initial adaptation in some users
Pea/legume allergy — rare; avoid if known pea protein allergy

Important Drug interactions

Metformin and other antidiabetics — Carb10's low GI profile is compatible; may require less medication adjustment vs. high-GI carb sources
No significant drug interactions